922 related articles for article (PubMed ID: 8864766)
1. Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
Singh J; Desiraju T; Raju TR
Indian J Physiol Pharmacol; 1996 Jan; 40(1):15-22. PubMed ID: 8864766
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor sub-types involvement in nucleus accumbens and ventral tegmentum but not in medial prefrontal cortex: on self-stimulation of lateral hypothalamus and ventral mesencephalon.
Singh J; Desiraju T; Raju TR
Behav Brain Res; 1997 Jul; 86(2):171-9. PubMed ID: 9134152
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic and GABAergic modulation of self-stimulation of lateral hypothalamus and ventral tegmentum: effects of carbachol, atropine, bicuculline, and picrotoxin.
Singh J; Desiraju T; Raju TR
Physiol Behav; 1997 Mar; 61(3):411-8. PubMed ID: 9089760
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of self-stimulation of ventral tegmentum by microinjection of opioid receptor subtype agonists.
Singh J; Desiraju T; Nagaraja TN; Raju TR
Physiol Behav; 1994 Apr; 55(4):627-31. PubMed ID: 7910690
[TBL] [Abstract][Full Text] [Related]
5. Effects of microinjections of cholecystokinin and neurotensin into lateral hypothalamus and ventral mesencephalon on intracranial self-stimulation.
Singh J; Desiraju T; Raju TR
Pharmacol Biochem Behav; 1997 Dec; 58(4):893-8. PubMed ID: 9408192
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of opioid peptides administered intracerebrally in loci of self-stimulation reward of lateral hypothalamus and ventral tegmental area--substantia nigra.
Singh J; Desiraju T
NIDA Res Monogr; 1988; 87():180-91. PubMed ID: 2855095
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
Godbout R; Mantz J; Pirot S; Glowinski J; Thierry AM
J Pharmacol Exp Ther; 1991 Aug; 258(2):728-38. PubMed ID: 1865369
[TBL] [Abstract][Full Text] [Related]
8. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
Pierce RC; Born B; Adams M; Kalivas PW
J Pharmacol Exp Ther; 1996 Jul; 278(1):384-92. PubMed ID: 8764374
[TBL] [Abstract][Full Text] [Related]
9. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
Rowlett JK; Platt DM; Yao WD; Spealman RD
J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
[TBL] [Abstract][Full Text] [Related]
10. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
Cory-Slechta DA; Widzowski DV; Newland MC
J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
[TBL] [Abstract][Full Text] [Related]
11. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
[TBL] [Abstract][Full Text] [Related]
12. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intracranial self-stimulation evoked from lateral hypothalamus and ventral tegmentum: analysis based on stimulation parameters and behavioural response characteristics.
Singh J; Desiraju T; Raju TR
Brain Res Bull; 1996; 41(6):399-408. PubMed ID: 8973846
[TBL] [Abstract][Full Text] [Related]
14. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
[TBL] [Abstract][Full Text] [Related]
15. [Participation of D1 dopamine and alpha2 adrenoreceptors in formation of the frequency spectrum of the cortical activity in rats].
Akhmetova ER; Vorob'ev VV; Groznyĭ AV; Kovalev GI
Eksp Klin Farmakol; 2000; 63(3):7-10. PubMed ID: 10934587
[TBL] [Abstract][Full Text] [Related]
16. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
[TBL] [Abstract][Full Text] [Related]
17. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
Olds ME
Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
[TBL] [Abstract][Full Text] [Related]
18. The role of neuropeptide CART in the lateral hypothalamic-ventral tegmental area (LH-VTA) circuit in motivation.
Somalwar AR; Shelkar GP; Subhedar NK; Kokare DM
Behav Brain Res; 2017 Jan; 317():340-349. PubMed ID: 27686026
[TBL] [Abstract][Full Text] [Related]
19. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Tidey JW; Bergman J
J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
[TBL] [Abstract][Full Text] [Related]
20. [A comparison of the effects of dopamine agonists on self-stimulation of the hypothalamus with destruction of the mesolimbic brain structures in rats raised under conditions of social isolation].
Panchenko GN; Lebedev AA; Shabanov PD
Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(5):937-43. PubMed ID: 9054146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
